Catazyme

Catazyme is a digestive enzyme formulation developed and marketed by Stadmed, primarily used to treat various forms of indigestion and dyspepsia. It is a combination product typically containing fungal diastase (a form of alpha-amylase) and pepsin. Fungal diastase acts as a starch-degrading enzyme, facilitating the breakdown of complex carbohydrates into simpler sugars, while pepsin is a proteolytic enzyme that aids in the digestion of dietary proteins by cleaving them into smaller peptides. This dual enzymatic action helps alleviate symptoms such as bloating, flatulence, and abdominal discomfort associated with enzyme deficiency or heavy meals. Catazyme is commonly available in oral liquid (syrup) and tablet forms as a commercial pharmaceutical product.

Brand names

Catazyme

Other names

fungal diastase + pepsinalpha-amylase + pepsin